Basic Information
Basic information for SNHG14-331-29aa
Peptide Name SNHG14-331-29aa
Genome Position chr15:25419914-25420000[+]
Species Human
Peptide Sequence METIQNSKNAPLTEKKAEKEEKIRQIENK
Peptide Length 29
Unique No (SNHG14-203-29aa,SNHG14-226-29aa,SNHG14-228-29aa,SNHG14-229-29aa,SNHG14-244-29aa,SNHG14-245-29aa,SNHG14-266-29aa,SNHG14-284-29aa,SNHG14-285-29aa,SNHG14-292-29aa,SNHG14-294-29aa,SNHG14-295-29aa,SNHG14-306-29aa,SNHG14-320-29aa,SNHG14-328-29aa,SNHG14-329-29aa)
Grand Average of Hydropathicity -1.6345
Relative Molecular Mass 3933.39
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000670384;SNHG14-331
Transcript Length 6331
Coding Ability 0.5122
DNA Sequence Corresponding to Peptide ATGGAGACAATACAAAATTCCAAAAATGCTCCATTAACCGAAAAGAAGGCAGAAAAGGAAGAAAAGATTAGACAAATAGAAAACAAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :